Nutrien Ltd. (NTR) Stock Forecast
NTR analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 3.76 / 5 from 25 analysts
- Price target
- $77.19 average of analyst targets
- Upside to target
- +8.3% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.77
- 52-week range
- $53.64 – $83.94
NTR analyst ratings
25 analystsNumber of analysts at each rating.
NTR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NTR earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.83 | $0.59 | $1.09 | $0.97 | −14.8% | 15 |
| Current fiscal year (2026) | $4.96 | $4.36 | $5.35 | $4.56 | +8.8% | 21 |
| Next fiscal year (2027) | $5.03 | $3.98 | $6.72 | $4.96 | +1.3% | 23 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NTR revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.66B | $5.48B | $5.75B | −1.4% | 7 |
| Current fiscal year (2026) | $27.69B | $27.10B | $28.77B | +6.7% | 15 |
| Next fiscal year (2027) | $27.49B | $26.42B | $31.38B | −0.7% | 16 |
NTR EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NTR revenue: reported and forecast
NTR EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.23 | $0.93 | $0.92 | $0.88 | $0.83 | −32.9% | 0 up · 3 down |
| Current fiscal year (2026) | $5.72 | $5.00 | $4.97 | $4.99 | $4.96 | −13.3% | 3 up · 2 down |
| Next fiscal year (2027) | $5.17 | $4.89 | $4.95 | $5.02 | $5.03 | −2.8% | 4 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NTR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NTR beat in 5 of 12.
What analysts expect from NTR
25 analysts cover Nutrien; their consensus rating is buy (3.76 on a 1–5 scale, where 5 is a strong buy). The average price target is $77.19, 8.3% above the latest close of $71.26. Analysts expect earnings of $4.96 per share for 2026, +8.8% from a year earlier. For 2027 the average estimate is $5.03 per share on revenue of $27.5 billion. Nutrien beat the EPS estimate in 5 of the last 12 quarters.
Related: NTR income statement, NTR key metrics, NTR chart. See the NTR stock overview for the latest quote and news.
NTR forecast FAQ
What is Nutrien's price target?
The average analyst price target for Nutrien is $77.19, 8.3% above the latest close of $71.26.
Is Nutrien a buy, hold or sell?
Of 25 analysts covering Nutrien, 8 rate it a strong buy, 7 a buy, 8 a hold, 0 a sell and 2 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Nutrien's EPS forecast?
Analysts forecast $4.96 per share for 2026 (range $4.36 to $5.35); for 2027 the estimate is $5.03.
What is Nutrien's revenue forecast?
The average revenue estimate for 2026 is $27.7 billion, growth of 6.7%; for 2027 it is $27.5 billion.
When does Nutrien report earnings?
Nutrien is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.77.
Does Nutrien usually beat earnings estimates?
Nutrien reported EPS at or above the analyst estimate in 5 of the last 12 quarters.